The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao

Table 3 Association between drug use and CT value alteration

Variables		CT value alteration (n = 883)
		Crude		Adjusted^a
		Linear coefficient ± S.E	p value	Linear coefficient ± S.E	p value
Dose of Lianhua Qingwen capsule	Low	0		0
	Middle	− 0.32 ± 0.16	0.05	− 0.37 ± 0.19	0.04
	High	0.12 ± 0.63	0.85	0.16 ± 0.65	0.81
Dose of Huoxiang Zhengqi capsule	Low	0		0
Dose of Huoxiang Zhengqi capsule	High	− 0.25 ± 0.18	0.17	− 0.37 ± 0.21	0.08
Duration of medicating	Low	0		0
	Middle	0.17 ± 0.17	0.31	0.24 ± 0.19	0.21
	High	0.40 ± 0.21	0.06	0.55 ± 0.24	0.02

The bold values pointed to statistical significance
^aModel was adjusted for demographic indices, personal habits and vaccination information (vaccination history, vaccine product and No. of days from last time)

ISSN: 1749-8546